Varduhi Ghazaryan
National Institutes of Health(US)National Institute of Allergy and Infectious Diseases(US)National Institutes of Health Clinical Center(US)
Publications by Year
Research Areas
Antibiotic Resistance in Bacteria, Antibiotics Pharmacokinetics and Efficacy, Antimicrobial Resistance in Staphylococcus, Bacterial Identification and Susceptibility Testing, COVID-19 Clinical Research Studies
Most-Cited Works
- → Baricitinib plus Remdesivir for Hospitalized Adults with Covid-19(2020)1,899 cited
- → Short- vs Standard-Course Outpatient Antibiotic Therapy for Community-Acquired Pneumonia in Children(2022)143 cited
- → Baricitinib versus dexamethasone for adults hospitalised with COVID-19 (ACTT-4): a randomised, double-blind, double placebo-controlled trial(2022)127 cited
- → Dalbavancin as an option for treatment of S. aureus bacteremia (DOTS): study protocol for a phase 2b, multicenter, randomized, open-label clinical trial(2022)51 cited
- → Prospective Validation of a Rapid Host Gene Expression Test to Discriminate Bacterial From Viral Respiratory Infection(2022)29 cited
- → Efficacy and safety of azithromycin versus placebo to treat lower respiratory tract infections associated with low procalcitonin: a randomised, placebo-controlled, double-blind, non-inferiority trial(2022)25 cited